Therapeutic uses for Angiotensin-(1-7)

被引：27
|
作者：
Machado-Silva, Alice [1 ]
Passos-Silva, Danielle [2 ]
Santos, Robson Augusto [2 ]
Sinisterra, Ruben Dario [3 ]
机构：
[1] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2016年 / 26卷 / 06期
关键词：
Angiotensin (1-7); Arg0; Mas receptor; PanCyte; TXA-127; RAS; IMPROVES LIPID-METABOLISM; ORAL FORMULATION; SKELETAL-MUSCLE; ENZYME; MAS; SYSTEM; BRAIN; INFLAMMATION; INHIBITION; PEPTIDE;
D O I：
10.1080/13543776.2016.1179283
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Introduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.
引用
收藏
页码：669 / 678
页数：10
相关论文
共 50 条
  • [41] Plasma angiotensin-(1-7) is decreased in preeclampsia
    Brosnihan, KB
    Karoly, M
    Merrill, D
    HYPERTENSION, 2000, 36 (04) : 696 - 696
  • [42] Angiotensin-(1-7) in normal and preeclamptic pregnancy
    Merrill, DC
    Karoly, M
    Chen, K
    Ferrario, CM
    Brosnihan, KB
    ENDOCRINE, 2002, 18 (03) : 239 - 245
  • [43] CENTRALLY ANGIOTENSIN-(1-7) DECREASES WITH AGE
    Gironacci, Mariela
    Sirri, Maria
    Carretero, Oscar
    Cerniello, Micaela
    JOURNAL OF HYPERTENSION, 2018, 36 : E10 - E10
  • [44] Angiotensins and the Heart Is Angiotensin-(1-7) Cardioprotective?
    Wysocki, Jan
    Wilsbacher, Lisa
    Batlle, Daniel
    HYPERTENSION, 2015, 66 (02) : 260 - 262
  • [45] Stabilization of Angiotensin-(1-7) in Cardioprotective Solutions
    Miriam Russ
    Susanne Jauk
    Reinhold Wintersteiger
    Bernd Gesslbauer
    Joachim Greilberger
    Michaela Andrä
    Astrid Ortner
    International Journal of Peptide Research and Therapeutics, 2019, 25 : 1271 - 1278
  • [46] Stabilization of Angiotensin-(1-7) in Cardioprotective Solutions
    Russ, Miriam
    Jauk, Susanne
    Wintersteiger, Reinhold
    Gesslbauer, Bernd
    Greilberger, Joachim
    Andrae, Michaela
    Ortner, Astrid
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2019, 25 (04) : 1271 - 1278
  • [47] Characterization of a new selective antagonist for angiotensin-(1-7), D-Pro7-angiotensin-(1-7)
    Santos, RAS
    Haibara, AS
    Campagnole-Santos, MJ
    Silva, ACSE
    Paula, RD
    Pinheiro, SVB
    Leite, MD
    Lemos, VS
    Silva, DMR
    Guerra, MT
    Khosla, MC
    HYPERTENSION, 2003, 41 (03) : 737 - 743
  • [48] Angiotensin-(1-7) as an antihypertensive, antifibrotic target
    Katovich, Michael J.
    Grobe, Justin L.
    Raizada, Mohan K.
    CURRENT HYPERTENSION REPORTS, 2008, 10 (03) : 227 - 232
  • [49] Angiotensin-(1-7) as a strategy in the treatment of hypertension?
    van Twist, Daan J. L.
    Kroon, Abraham A.
    de Leeuw, Peter W.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (05): : 480 - 486
  • [50] Pathways of angiotensin-(1-7) metabolism in the kidney
    Chappell, MC
    Allred, AJ
    Ferrario, CM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 22 - 26
12345